Osiris announces a strategic partnership with Stryker
Osiris announced it has entered into an exclusive, worldwide partnership with Stryker for commercialization and development of Osiris' viable bone matrix tissue form. The Agreement provides Stryker with exclusive, worldwide rights to Osiris' viable bone matrix under the name BIO4 ™. December 22, 2014